These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The effect of extreme acid and alkali changes upon the echogenicity of blood. Ramos JR; Sigel B; Machi J; Lu S; Levine MH; Hoover RP; Samuel SP; Robertson AL J Ultrasound Med; 1985 Oct; 4(10):513-8. PubMed ID: 4057343 [TBL] [Abstract][Full Text] [Related]
8. Red cell aggregation as a cause of blood-flow echogenicity. Sigel B; Machi J; Beitler JC; Justin JR Radiology; 1983 Sep; 148(3):799-802. PubMed ID: 6878705 [TBL] [Abstract][Full Text] [Related]
9. Coagulopathy screening in children with heparinized central venous catheters. Ellis MR Pediatrics; 1993 Jun; 91(6):1147-50. PubMed ID: 8502518 [TBL] [Abstract][Full Text] [Related]
10. Heparin neutralization by recombinant platelet factor 4 and protamine. Levy JH; Cormack JG; Morales A Anesth Analg; 1995 Jul; 81(1):35-7. PubMed ID: 7598278 [TBL] [Abstract][Full Text] [Related]
11. At high heparin concentrations, protamine concentrations which reverse heparin anticoagulant effects are insufficient to reverse heparin anti-platelet effects. Carr ME; Carr SL Thromb Res; 1994 Sep; 75(6):617-30. PubMed ID: 7831681 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass. Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162 [TBL] [Abstract][Full Text] [Related]
13. Quantification of erythrocyte aggregation by blood echogenicity: a preliminary study. Razavian SM; Levenson J; Peronneau P; Simon A J Cardiovasc Surg (Torino); 1995 Aug; 36(4):375-7. PubMed ID: 7593150 [TBL] [Abstract][Full Text] [Related]
14. [Effect of regulating blood clotting with heparin and its antagonists on mast cells]. Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304 [TBL] [Abstract][Full Text] [Related]
15. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study. Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778 [TBL] [Abstract][Full Text] [Related]
17. The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Yang VC; Port FK; Kim JS; Teng CL; Till GO; Wakefield TW Anesthesiology; 1991 Aug; 75(2):288-97. PubMed ID: 1859016 [TBL] [Abstract][Full Text] [Related]
18. Can protamine be used during perfusion with heparin surface coated equipment? von Segesser LK; Gyurech DD; Schilling JJ; Marquardt K; Turina MI ASAIO J; 1993; 39(3):M190-4. PubMed ID: 8268526 [TBL] [Abstract][Full Text] [Related]
19. Reversal of protamine of the prolonged response to intrapulmonary heparin. Wright CJ; Mahadoo J; Jaques LB Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967 [TBL] [Abstract][Full Text] [Related]